ArticleFrontiers in immunology2023

Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression.

Afsheen Raza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.